Christos Sotiriou, MD, PhD, graduated from the Medical School from the Université Libre de Bruxelles, Belgium and obtained his Medical Oncology Specialization in 1999. He graduated with a PhD in genomics in 2004.
He is currently Professor in the Medical Department of Medical Oncology at the Jules Bordet Institute and Research Director at the National Fund for Scientific Research (FNRS) in Belgium.
His research work consists in improving the molecular understanding of breast cancer biology, disease dissemination and progression using state-of-the art “omics” technologies as well as identifying novel prognostic and predictive biomarkers. The ultimate goal of his laboratory is to accelerate the translation of basic science discoveries dedicated to breast cancer into the clinic. His group, composed of 20 persons, is a well-diversified multidisciplinary team integrating translational research post-docs, clinical research fellows, bioinformatic and wet lab PhD students as well as laboratory technicians allowing a combined understanding of breast cancer biology and up-to-date knowledge of clinical practice.
Professor Sotiriou’s work has resulted in several patents and in over 250 original research publications, including numerous papers in New England Journal of Medicine, Nature, Nature Medicine, PNAS, JNCI, Journal of Clinical Oncology, Lancet Oncology. He is the recipient of several prestigious national and international awards.
He was Member of the TransALTTO committee of the Breast International Group (BIG) and an Executive Chair/Co-organizer/Member of the Executive Committee of the IMPAKT international conference (2009 to 2017). He is currently member of several scientific committees for international meetings, including SABCS, AACR, EBCC, ECCO and ESMO. He served as advisory council member of the Susan G. Komen for the Cure from 2010 to 2016 and an elected member of the scientific council of the International Agency for Research on Cancer (IARC - World Health Organization) from 2012 to 2016. He is elected as Fellow of the European Academy of Cancer Sciences in October 2010 and associated editor of Annals of Oncology since 2014. He is also a core Faculty Member of the European School of Oncology since 2017.